Kintara Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaborations
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Events
    • Recent News
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Publications and Abstracts

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Events
  • Recent News

DelMar's Interim Data Presentation at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)

May 31, 2014

DelMar's permanent abstract (#TPS2109) at American Society of Clinical Oncology (ASCO)

May 31, 2014

DelMar's Abstract "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer" at American Association of Cancer Research (AACR) Annual Meeting

Apr 9, 2014

DelMar's Abstract "Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme" at American Association of Cancer Research (AACR) Annual Meeting

Apr 6, 2014

DelMar's Presentation Poster for VAL-083 in Glioblastoma at Society for Neuro-Oncology (SNO)

Dec 4, 2013

DelMar's Presentation Poster "The unique mechanism of action of VAL-083 may provide a new treatment option for some chemo-resistant cancers" at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 21, 2013

DelMar's Presentation Poster from Ongoing Brain Cancer Study at ASCO

Jun 1, 2013

DelMar's Presentation Poster "In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer" at American Association of Cancer Research (AACR) Annual Meeting

Apr 1, 2013

DelMar's Presentation Poster "Phase I/II Study of VAL-083 in Patients with Recurrent Malignant Glioma or Progressive-Secondary Brain Tumor" at Society for Neuro-Oncology (SNO) Annual Meeting 2012

Nov 1, 2012

DelMar's Presentation Poster "Phase I/II Study of VAL-083 in Patients with Recurrent Malignant Glioma or Progressive-Secondary Brain Tumor" at Society for Neuro-Oncology (SNO) Annual Meeting 2012

Nov 1, 2012
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
© 2022 Kintara Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences